Back to search

Article

Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis

2025-07-29

Abstract excerpt

Half of advanced melanoma patients fail to benefit from immune checkpoint blockade and novel treatments are urgently required. Testing topical medications used in other skin diseases for anti-cancer activity in an immunotherapy-resistant murine melanoma model, we counterintuitively found that glucocorticoids elicit rapid cytotoxic T lymphocyte (CTL)-dependent tumor control. Genetic ablation of the glucocorticoid r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
35d8d4d3-e10c-5044-8eb9-63be0451b1b4
DOI
10.1101/2025.07.24.666619
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axisDOI 10.1101/2025.07.24.666619
Select a neighboring publication to make it the new centre.